Overcoming barriers to delivery of biologics by novel approaches and advanced delivery systems

Biologics is emerging as fastest growing field of drug development offering specificity and high therapeutic potential. However, their therapeutic efficacy is dependent on their route of administration and targeted delivery. Unlike small molecules, biologics face stability, permeability, solubility and immunogenicity challenges due to their inherent features. Hence tailored approaches are required in formulation development to assure their time-and site-specific action. In this review, we summarized the general and route-specific barriers that this group of drugs encounter once in contact with administration site. We listed the most common approaches to overcome the barriers and presented examples of different delivery systems that were proposed to deal with route-specific challenges. We also addressed the role devices play in assisted drug delivery and their choices related to expected use. We highlighted device-biologic combinations and discussed our perspectives on improving development using machine learning.

Authors

Institutions

Publication Details

Journal
Advanced Drug Delivery Reviews
Published
2026-04-16
DOI
https://doi.org/10.1016/j.addr.2026.115875
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Overcoming barriers to delivery of biologics by novel approaches and advanced delivery systems

Gøril Eide Flaten, Giulia Anderluzzi, Stephen Dela Ahator, Silvia Franzè et al.
Advanced Drug Delivery Reviews
Monoclonal and Polyclonal Antibodies Research
article

Overcoming barriers to delivery of biologics by novel approaches and advanced delivery systems

Gøril Eide Flaten, Giulia Anderluzzi, Stephen Dela Ahator, Silvia Franzè, Sybil Akua Okyerewa Obuobi, Nataša Škalko‐Basnet
article en

Abstract

Biologics is emerging as fastest growing field of drug development offering specificity and high therapeutic potential. However, their therapeutic efficacy is dependent on their route of administration and targeted delivery. Unlike small molecules, biologics face stability, permeability, solubility and immunogenicity challenges due to their inherent features. Hence tailored approaches are required in formulation development to assure their time-and site-specific action. In this review, we summarized the general and route-specific barriers that this group of drugs encounter once in contact with administration site. We listed the most common approaches to overcome the barriers and presented examples of different delivery systems that were proposed to deal with route-specific challenges. We also addressed the role devices play in assisted drug delivery and their choices related to expected use. We highlighted device-biologic combinations and discussed our perspectives on improving development using machine learning.

Advanced Drug Delivery ReviewsVol. 234
University of Milan (IT), UiT The Arctic University of Norway (NO)
Openalex Percentile: Top 18%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.